Using 4th generation e-cigarettes to help African American smokers quit traditional cigarettes
4th Generation e-cigarettes in African American Smokers: Reducing Harm and Quitting Combustible Cigarettes in Dual Users
This study is looking at whether 4th generation e-cigarettes can help African American smokers who also smoke regular cigarettes switch to e-cigarettes, making it easier for them to quit and reduce health risks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11032734 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of 4th generation e-cigarettes as a harm reduction strategy for African American smokers who also use combustible cigarettes. It aims to understand how these e-cigarettes can help dual users switch exclusively to e-cigarettes, thereby reducing their tobacco-related health risks. The study will involve a randomized controlled trial to compare the outcomes of participants who use e-cigarettes versus those who continue smoking traditional cigarettes. The research also seeks to develop supportive interventions for those who struggle to quit combustible cigarettes.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American adults who currently smoke combustible cigarettes and are interested in switching to e-cigarettes.
Not a fit: Patients who do not smoke or are not interested in using e-cigarettes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a viable pathway for African American smokers to reduce harm from tobacco use and improve their overall health.
How similar studies have performed: Previous studies have shown promise in using e-cigarettes as a harm reduction tool, but this specific approach targeting African American dual users is novel.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Nollen, Nicole L — University of Kansas Medical Center
- Study coordinator: Nollen, Nicole L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.